Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing lipophilic 4-imidazolyl substituents

Arzneimittel-Forschung/Drug Research

Volumn 54, Issue 9, 2004, Pages 499-504

  Navidpour, Latifeh ^a   Miri, Ramin ^b   Shafiee, Abbas ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

1,4 Dihydropyridines, 2 phenyl imidazole substituents; Calcium channel antagonists; CAS 21829 25 4; Nifedipine, analogues

Indexed keywords

BENZENE DERIVATIVE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CYCLOALKANE DERIVATIVE; CYCLOHEXYLMETHYL 1,4 DIHYDRO 2,6 DIMETHYL 4 [2 PHENYL 4(5) IMIDAZOLYL] 3,5 PYRIDINEDICARBOXYLATE; DICYCLOHEXYL 1,4 DIHYDRO 2,6 DIMETHYL 4 [2 PHENYL 4(5) IMIDAZOLYL] 3,5 PYRIDINEDICARBOXYLATE; IMIDAZOLE DERIVATIVE; METHYL GROUP; NIFEDIPINE; NIFEDIPINE DERIVATIVE; POTASSIUM; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CHANNEL GATING; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; ILEUM; IN VITRO STUDY; INTESTINE MUSCLE; LIPOPHILICITY; MALE; NONHUMAN; SMOOTH MUSCLE CONTRACTION; STRUCTURE ACTIVITY RELATION;

EID: 4644296185     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1297004     Document Type: Article

References (27)

1. Zamponi, G. W., Antagonist sites of voltage-dependent channels. Drug. Dev. Res. 42, 131 (1997)
2. 2+ channel ligands: Structure-function relationship of the 1,4-dihydropyridines. Med. Res. Rev. 9, 123 (1989)
3. Striessnig, J., Pharmacology, structure and function of cardiac L-type calcium channels. Cell Physiol. Biochem. 9, 242 (1999)
4. New analyses regarding the safety of calcium channel blockers: A statement for health professionals from the National Hearth, Lung, and Blood Institute, September 1, 1995. http://www.nhlbi.nih.gov/new/press/cutlrccb.txt.
5. Psaty, B. M., Heckbert, S., Koepsell, T. et al., The risk of myocardial infarction associated with antihypertensive drug therapy. J. Am. Med. Assoc. 274, 620 (1995)
6. Pahor, M., Guralnik, J. M., Ferruci, L. et al., Calcium channel blockade and incidence of cancer in aged populations. Lancet 348, 493 (1996)
7. Fitzpatrick, A. L., Daling, J. R., Furberg, C. D. et al., Use of calcium channel blockers and breast carcinoma risk in postmenopausal women. Cancer 80, 1438 (1997)
8. Joint National Committee. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of high Blood Pressure (JNC-VI). Arch. Intern. Med. 157, 2413 (1997)
9. Coburn, R. A., Wierzba, M., Suto, M. J. et al., 1,4-Dihydropyridine antagonist activities at the calcium channel: a quantitative structure-activity relationship approach. Med. Chem. 31, 2103 (1988)
10. 2+ channel antagonists. J. Med. Chem. 26, 775 (1983)
11. Schramm, M., Thomas, G., Towart, R. et al., Nature 303, 535 (1983)
12. Natale, N. R., Rogers, M. E., Staples R. J. et al., Lipophilic 4-isoxazolyl-1,4-dihydropyridines: Synthesis and structure-activity relationships. J. Med. Chem. 42, 3087 (1999)
13. Zamponi, G. W., Stotz, S. C., Staples R. J. et al., Unique structure-activity relationship for 4-isoxazolyl-1,4-dihydropyridines. J. Med. Chem. 46, 87 (2003)
14. Ramesh, M., Matowe, W. C., Wolowyk, M. W. et al., Synthesis and calcium channel antagonist activity of alkyl, t-butyl esters of nifedipine containing pyridinyl substituents. Drug Design & Delivery 2, 79 (1987)
15. Akula, M. R., Matowe, W. C., Wolowyk, M. W. et al., Synthesis and calcium channel antagonist activity of alkyl, cycloalkyl esters of nifedipine containing pyridinyl substituents. Drug Design Delivery 5, 117 (1989)
16. Ramesh, M., Matowe, W.C., Wolowyk, M. W. et al., Synthesis and calcium channl modulating effects of alkyl or (cycloalkyl) 1,4-dihydro-2,6-dimethyl-3- nitro-4-pyridyl-5-pyridine carboxylate. Pharm. Res. 7, 919 (1990)
17. Shaflee, A., Miri, R., Dehpour, A. R., Synthesis and calcium channel antagonist activity of nifedipine analogues containing nitroimidazolyl substituents. Pharm. Sci. 2, 541 (1996)
18. Pourmorad, F., Hadizadeh, E, Shafiee, A., Synthesis and calcium-channel antagonist activity of 4-imidazolyl-1,4-dihydropryridines. Pharm. Sci. 3, 165 (1997)
19. Shafiee, A., Dehpour, A. R., Hadizadeh, F., Synthesis and calcium channel antagonist activity of nifedipine analogues with methylsulfonylimidazolyl substituent. Pharm. Acta Helv. 73, 75 (1998)
20. Amini, M., Golabchifar, A. A., Dehpour, A. R. et al., Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing dichloroimidazolyl substituents. Arzneim.-Forsch./Drug Res. 52 (1), 21 (2002)
21. Shafiee, A., Rastkary, N., Jorjani M., Synthesis and calcium channel antagonist activity of 1,4-dihydropyridine derivatives containing 4-nitroimidazolyl substituents. Arzneim.-Forsch./Drug Res. 52 (1), 537 (2002)
22. Clemense, R. J., Hyatt, H. A., Acetoacetylation with 2,2,6-trimethyl-4H- 1,3-dioxine-4-one: a convenient alternative to diketen. J. Org. Chem. 50, 2431 (1985)
23. Hantzsch, A., Über die synthese pyridinartiger Verbindungen aus Acetessigather und Aldehydammoniak. Justus Liebigs Ann. Chem. 215, 1 (1882)
24. Meyer, H., Bossert, F., Wehinger, E. et al., Synthese und Vergleichende Pharmakologische Untersuchungen von 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)- pyridine-3,5-carbosäureestern mit nicht-identischen Esterfunktionen. Arzneim.-Forsch./Drug Res. 31 (1), 407 (1981)
25. Sircar, I., Bobowski, G., Bristol, J. A. et al., Cardiotonic agents. Synthesis and biological activity of novel 6-(substituted 1H-imidazol-4(5)-yl)- 3(2)H-pyridazinone. J. Med. Chem. 29, 261 (1986)
26. 3H] nitrendipine to guinea pig ileal smooth muscle. J. Pharm. Exp. Ther. 225, 291 (1983)
27. Rovnyak, G. C., Atwal, K. S., Hedberg, A., Dihydropyridine calcium channel blockers: 3-substituted-4-aryl-1,4-dihydropyridine-5-carboxylic acid esters, Potent antihypertensive agent. J. Med. Chem. 35, 3236 (1992)